← Association for Accessible Medicines
FDANonrulemakingFDA-2023-N-3721

Quality Management Maturity Program for Drug Manufacturing Establishments; Establishment of a Public Docket; Request for Comments

RIN
—
Last modified
Dec 15, 2023
Comment window
closed 957d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Nov 28, 2023 and Nov 28, 2023. 1 other organizations filed here. The comment window closed 957d ago.

What Association for Accessible Medicines filed (1)

Nov 28, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2023-N-3721-0005

FDA, Please find attached comments from The Association for Accessible Medicines (AAM) regarding Docket No. FDA–2023–N–3721, "Quality Management Maturity Program for Drug Manufacturing Establishments; Establishment of a Public Docket; Request for Comments" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs Association for Accessible Medicines

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (1)

See everyone who commented →